Press release
Global Industry Figures Show Staggering Increase in Chronic Kidney Disease
chronic kidney disease
The chronic kidney disease is characterized by the gradual loss of kidney function over the period. If left untreated, it may lead to kidney failure. Type 1 or Type 2 diabetes, high blood pressure, glomerulonephritis, interstitial nephritis, polycystic kidney disease, and others are the common indications for the chronic kidney disease. The disease can be treated through administration of drugs at the early stage and dialysis and kidney transplant at the last stage. treatment methods focus on preventing kidney damage, while at the end-stage it is treated through dialysis and kidney transplant.
Get Exclusive Sample of Report @ https://www.marketresearchfuture.com/sample_request/5744
Key drivers for the growth of the market are increasing the prevalence of kidney diseases, increasing number of biopsy procedures, and the rising demand for new techniques for diagnosis of chronic diseases. Moreover, the availability of various diagnostic tests for kidney diseases also influences the growth of the market. The increasing number of market players is also expected to stimulate the growth of the market during the forecast period. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) stated that the kidney disease is frequently referred to as a “silent disease” as there are no symptoms in its early stages and can go undetected. The disease is a global health burden risk factor for Cardiovascular Diseases (CVDs). It also stated that the overall prevalence of chronic kidney disease in the general population is nearly 14%.
Global Chronic Kidney Disease Market Players:
Abbott, Siemens, Sysmex, Beckman Coulter, F. Hoffmann-La Roche Ltd, ACON Laboratories, Inc., URIT Medical, Nova Biomedical, ARKRAY, OPTI Medical, 77 Elektronika, Randox Laboratories, Teva Pharmaceutical Industries Ltd., Amgen Inc., AstraZeneca Plc, Pfizer Inc., F. Hoffmann-La Roche Ltd., Sanofi S.A., GlaxoSmithKline Plc, AbbVie Inc., and Kissei Pharmaceutical Co. Ltd.
Chronic Kidney Disease Market Segmentation:
The global chronic kidney disease market is segmented on the basis of diagnosis, treatment, indication, and end-user. On the basis of diagnosis, it is segmented into blood test, urine test, imaging test, and kidney biopsy. On the basis of treatment, it is segmented into drugs, dialysis, and kidney transplant. Drugs are further segmented into ace inhibitors, angiotensin-ii receptor blockers, calcium channel blockers, beta-blockers, and erythropoiesis-stimulating agents. On the basis of indication, it is segmented into Type 1 or Type 2 diabetes, high blood pressure, polycystic kidney disease, and others. On the basis of end-user, it is segmented into hospitals and clinics, diagnostic centers, and others.
Chronic Kidney Disease Market Regional Analysis:
The American chronic kidney disease market is driven by the increasing population with kidney diseases, extensive use of diagnostic tests for detecting kidney failure, and the increasing demand for new treatment options for kidney diseases.
In Europe, the market is driven by the growth of the medical device industry and the increasing awareness about risk factors for kidney diseases. Additionally, the increasing diabetic population and huge investments in the medical device sector by major market players also fuel the growth of the market. Germany, the largest market for chronic kidney diseases, is driven by the increasing emphasis on the development of new drugs, rising government support for research and development, and availability of funds for research.
Asia Pacific is the fastest growing chronic kidney disease market owing to the increasing prevalent diseases such as diabetes and cardiovascular diseases. Improving hospital infrastructure, the presence of skilled healthcare professionals, and rapid development in the healthcare technology are also expected to accelerate the growth of the market during the forecast period.
The Middle East and Africa hold the least share of the chronic kidney disease market due to limitations to technology and unawareness about kidney diseases and their treatments.
Browse Complete Report @ https://www.marketresearchfuture.com/reports/chronic-kidney-disease-market-5744
Some of Major Table of Content for Chronic Kidney Disease Markett:
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
TOC Continued….!
Get Discount @ https://www.marketresearchfuture.com/check-discount/5744
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com .
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Industry Figures Show Staggering Increase in Chronic Kidney Disease here
News-ID: 1098267 • Views: …
More Releases from Market Research Future Reports
Wet Glue for Labelling Market Poised for Expansion Thanks to Eco-Friendly Soluti …
Recent market research indicates that the wet glue for labelling market was valued at USD 7,015.4 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of around 6.41% from 2024 to 2032. This trajectory reflects both steady demand from established end-use industries and new opportunities created by brand owners seeking differentiation through packaging.
Download Exclusive Sample Copy of this Report here: https://www.marketresearchfuture.com/sample_request/22229
Growth Drivers and…
Elevators and Escalators Market Navigating Business with CAGR of 8.76% with Reve …
The elevators and escalators market has been experiencing steady growth over the past decade due to rapid urbanization, the rise in high-rise buildings, and the growing importance of vertical transportation in the global economy. With increasing infrastructure development in both developed and emerging countries, the demand for elevators and escalators has surged significantly. Technological advancements, energy efficiency improvements, and a focus on passenger safety have further propelled the industry forward,…
Hydroponics Substrate Market Size, Analytical Overview, Growth Factors, Demand a …
Introduction
The hydroponics substrate market has witnessed remarkable growth in recent years, driven by the increasing adoption of hydroponic farming methods worldwide. As a soil-free, water-based system, hydroponics offers a controlled environment that promotes faster growth, higher yields, and efficient resource use compared to traditional agriculture. Substrates play a crucial role in hydroponic systems, acting as mediums to anchor plants while allowing for efficient nutrient and water delivery. The choice of…
Marine Grease Market 2024-2032: Emerging Trends, Growth Opportunities, Growth An …
The marine grease market is a key segment of the global lubrication industry, catering to the unique demands of the maritime sector. Grease, an essential lubricant, plays a critical role in maintaining the performance and longevity of marine equipment and machinery. As the global maritime industry continues to expand, driven by rising international trade, tourism, and naval operations, the demand for specialized marine greases is growing steadily. This article explores…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
